Authors:
Rakotoambinina, B
Medioni, J
Rabian, C
Jubault, V
Jais, JP
Viard, JP
Citation: B. Rakotoambinina et al., Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor, J ACQ IMM D, 27(5), 2001, pp. 443-449
Authors:
Kirk, O
Mocroft, A
Pradier, C
Bruun, JN
Hemmer, R
Clotet, B
Miller, V
Viard, JP
Phillips, AN
Lundgren, JD
Citation: O. Kirk et al., Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir, AIDS, 15(8), 2001, pp. 999-1008
Authors:
Gougeon, ML
Rouzioux, C
Liberman, I
Burgard, M
Taoufik, Y
Viard, JP
Bouchenafa, K
Capitant, C
Delfraissy, JF
Levy, Y
Citation: Ml. Gougeon et al., Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients, AIDS, 15(13), 2001, pp. 1729-1731
Authors:
Viard, JP
Mocroft, A
Chiesi, A
Kirk, O
Roge, B
Panos, G
Vetter, N
Bruun, JN
Johnson, M
Lundgren, JD
Citation: Jp. Viard et al., Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence fromthe EuroSIDA study, J INFEC DIS, 183(8), 2001, pp. 1290-1294
Authors:
Zylberberg, H
Nalpas, B
Pol, S
Brechot, C
Viard, JP
Citation: H. Zylberberg et al., Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?, AIDS, 14(13), 2000, pp. 2055-2055
Authors:
Jubault, V
Penfornis, A
Schillo, F
Hoen, B
Izembart, M
Timsit, J
Kazatchkine, MD
Gilquin, J
Viard, JP
Citation: V. Jubault et al., Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients, J CLIN END, 85(11), 2000, pp. 4254-4257
Authors:
Jubault, V
Pacanowski, J
Rabian, C
Viard, JP
Citation: V. Jubault et al., Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy, ANN MED IN, 151(3), 2000, pp. 163-168
Authors:
Mocroft, A
Madge, S
Johnson, AM
Lazzarin, A
Clumeck, N
Goebel, FD
Viard, JP
Gatell, J
Blaxhult, A
Lundgren, JD
Citation: A. Mocroft et al., A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival, J ACQ IMM D, 22(4), 1999, pp. 369-378
Authors:
Zou, WP
Foussat, A
Houhou, S
Durand-Gasselin, I
Dulioust, A
Bouchet, L
Galanaud, P
Levy, Y
Emilie, D
Aboulker, JP
Capitant, C
Boue, F
Bouvet, E
Karmochkinc, M
Kazatchkine, M
Oksenhendler, E
Viard, JP
Weiss, L
Yeni, P
Delfraissy, JF
Goujard, C
Jarrousse, B
Lepeu, G
Cartier, F
Bazin, C
Six, M
Gastaut, JA
Seligmann, M
Herrerra, A
Maral, J
Citation: Wp. Zou et al., Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, AIDS, 13(4), 1999, pp. 455-463
Authors:
Levy, Y
Capitant, C
Houhou, S
Carriere, I
Viard, JP
Goujard, C
Gastaut, JA
Oksenhendler, E
Boumsell, L
Gomard, E
Rabian, C
Weiss, L
Guillet, JG
Delfraissy, JF
Aboulker, JP
Seligmann, M
Citation: Y. Levy et al., Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, LANCET, 353(9168), 1999, pp. 1923-1929
Authors:
Dupin, N
De Cervens, VR
Gorin, I
Calvez, V
Pessis, E
Grandadam, M
Rabian, C
Viard, JP
Huraux, JM
Escande, JP
Citation: N. Dupin et al., The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma, BR J DERM, 140(5), 1999, pp. 875-881
Authors:
Saraux, A
Jouquan, J
Le Goff, P
Youinou, P
Levy, Y
Piette, JC
Guillevin, L
Semana, G
Salmon, D
Viard, JP
Bach, JF
Shoenfeld, Y
Citation: A. Saraux et al., Environmental factors may modulate antiphospholipid antibody production infamily members of patients with systemic lupus erythematosus, ARTH RHEUM, 42(5), 1999, pp. 1062-1064